Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinical Research for CEOs: A guide to good business practice and the conduct of clinical trials.

This article was originally published in Clinica

Executive Summary

Regulations do not always provide answers to how best conduct clinical trials. The US's Investigational Device Exemptions (IDEs) and Europe's regulations governing trials to establish device performance in support of obtaining a CE marking (EN 540) give only the sketchiest guidance. Nor are all clinical trials regulated. By stating that trials conducted in support of obtaining a CE marking are subject to EN540, Europe's Active Implantable Medical Directive and Medical Directive leave, by inference, trials conducted for other purposes free from the need to comply with EN540. In the US, IDE's actually provide for exempt clinical trials. In general, such unregulated trials are those conducted on commercial devices used in accordance with approved labelling, trials conducted to determine characteristics other than safety, efficacy or performance, or trials conducted on in vitro diagnostic devices. In these cases the regulations either do not provide guidance or they do not apply at all, and each manufacturer is left to determine how the ethics of good clinical practices will be applied to sponsored clinical research. The following are the most frequently asked about clinical trials.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089821

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel